Donà Federico, Erratico Silvia, Terracciano Luigi Maria, Brascia Debora, Cecconi Emanuela Re, Giudici Veronica Maria, Bossi Paola, Ng Charlotte K Y, Marulli Giuseppe, Piscuoglio Salvatore
IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy.
IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy.
STAR Protoc. 2025 Jul 2;6(3):103923. doi: 10.1016/j.xpro.2025.103923.
Organoids are vital for studying cancer mechanisms and treatment resistance, but their growth usually depends on costly, animal-derived Matrigel. Here, we present a protocol for expanding and maintaining lung-derived organoids without the need for Matrigel. We describe steps for establishing lung cancer organoids, staining organoids for immunohistochemistry, and cultivating them with ClinoStar. By eliminating dependence on Matrigel and its associated costs, this protocol enhances accessibility and scalability, making organoid-based research more feasible for cancer studies and therapeutic development.
类器官对于研究癌症机制和治疗抗性至关重要,但其生长通常依赖于昂贵的、动物来源的基质胶。在此,我们提出了一种无需基质胶即可扩增和维持肺来源类器官的方案。我们描述了建立肺癌类器官、对类器官进行免疫组织化学染色以及使用ClinoStar培养它们的步骤。通过消除对基质胶及其相关成本的依赖,该方案提高了可及性和可扩展性,使基于类器官的研究在癌症研究和治疗开发中更可行。